Pharmaceutics International, Inc. Data Breach

**Pharmaceutics International, Inc. Reports Major Data Breach Exposing Sensitive PII** Pharmaceutics International, Inc. (Pii), a prominent contract development and manufacturing organization in the pharmaceutical sector, has disclosed a significant data breach involving highly sensitive personally identifiable information (PII). The incident was reported to the Massachusetts Attorney General’s office on **December 23, 2025**, with at least **five Massachusetts residents confirmed impacted**—though the total number of affected individuals may rise as the investigation continues. The breach exposed a broad range of personal data, including **full names, Social Security numbers, dates of birth, current and former addresses, government-issued IDs, Social Security cards, pay stubs, and W-2 forms**. The scope of the exposed information heightens the risk of **identity theft and financial fraud**, though the company has not yet identified the attack vector or responsible threat actor. In response, Pii **secured its systems, initiated a comprehensive incident review, and is reassessing its security protocols** to prevent future breaches. Regulatory notifications have been filed as required by law. Affected individuals are being offered **complimentary credit monitoring and identity protection services through Kroll**, along with a dedicated call center for inquiries (**844-354-1388**, Monday–Friday, 9 a.m.–6:30 p.m. ET). The investigation remains ongoing, with no further details on the breach’s origin or potential broader impact.